Clinical aspects of pandemic 2009 influenza A (H1N1) virus infection.

By Edgar Bautista, T. Chotpitayasunondh, Zhancheng Gao, S. Harper, M. Shaw, T. Uyeki, S. Zaki, F. Hayden, D. Hui, J. Kettner and 5 more. New England Journal of Medicine, 2010

999 citations recorded by the source corpus.

Subfields: Epidemiology, Infectious Diseases

View Paper: https://www.semanticscholar.org/paper/5d715f7baacc1f6735c12caedbf8dd45015896d0

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

1. A. Fiore
2. Taisheng Li
3. A. Fry
4. L. Gubareva
5. Ling Lin
6. D. Shay
7. J. Bresee
8. Lianfeng Lu

Citations in the corpus

• Antiviral agents for the treatment and chemoprophylaxis of influenza --- recommendations of the Advisory Committee on Immunization Practices (ACIP). (2011, methodology): “However, treatment of any person with confirmed or suspected influenza who requires hospitalization is recommended, even if the patient presents >48 hours after illness onset (12,28,51,105).”
• Hypothesis for potential pathogenesis of SARS-CoV-2 infection–a review of immune changes in patients with viral pneumonia (2020, background): “Extra-pulmonary presentations like gastrointestinal, neurologic and cardiac dysfunction, have also been described in the review [26] .”